Systems and methods for managing blood donations

Information

  • Patent Grant
  • 11426498
  • Patent Number
    11,426,498
  • Date Filed
    Monday, June 1, 2015
    9 years ago
  • Date Issued
    Tuesday, August 30, 2022
    2 years ago
Abstract
Apparatuses and methods of using them to collect blood, are provided, by first ensuring that the patient's skin is properly cleaned, to prevent contamination of the collected blood. One feature is a blood collection device configured to collect blood from a patient. Another feature is a scrub timer integrated into the device and configured to indicate to a user a scrub time period prior to beginning a blood draw process. The scrub timer can be configured to audibly and/or visually indicate to a user the start and stop times of a scrub cleaning process. In one embodiment, the scrub timer can be restarted, either manually or automatically, if the scrub cleaning process is not followed properly.
Description
INCORPORATION BY REFERENCE

All publications, including patents and patent applications, mentioned in this specification are herein incorporated by reference in their entirety to the same extent as if each individual publication was specifically and individually indicated to be incorporated by reference.


FIELD

Described herein are devices and methods for use in blood donation and blood management. In particular, described herein are devices and methods for acquiring blood donations.


BACKGROUND

Blood collection from a donor typically requires piercing the subject's skin with a needle, usually after the area of the subject's skin to be pierced is cleaned (e.g., with alcohol, iodine, or the like). Bacteria present on the skin can enter the blood component collecting bag together with the blood. Indeed, it has been found that some kinds of skin-borne bacteria that may enter the blood collecting bag in this manner may multiply even if blood collecting bag is kept cold. When the collected blood is transfused into a patient, the patient may suffer from infectious disease or blood poisoning.


Although most phlebotomists are trained in techniques to wash or prepare the skin prior to collecting blood, there is a great deal of variability and simple human error associated with collection of blood. For example, the time required to adequately prepare the skin site for needle penetration, including both washing and drying the skin, is not standardized. Even where standard times are applied for each of these steps (e.g., 30 second scrub time), the phlebotomist is generally expected to time herself or himself. Thus, there is a potential for further error and variability which may result in contamination of the collected blood.


The current technique used by most phlebotomists allows the phlebotomist to use a time piece to time a scrubbing procedure, generally their own watch or a clock on the wall. In many instances, a phlebotomist may use one time piece, such as their watch, to initiate a scrubbing procedure, and may then use another time piece, such as a clock on the wall, to monitor the end of the scrubbing procedure. Non-compliance with standardized scrub times can result when the time is not synchronized between these two time pieces. When non-compliance is observed by the FDA, the blood center can be given a 483 non-compliance write-up and be required to respond with a Corrective and Preventative Action, which costs the blood center both time and money.


In view of this and other problems, there is a need for tools, including blood collection apparatuses that may help address these issues. In particular, described herein are blood collection devices that are adapted to provide multiple easy-to-use and accurate timers that may guide the phlebotomist in preparing the subject's skin, and can prevent collection from improperly cleaned skin, as well as methods of using such devices.


SUMMARY OF THE DISCLOSURE

In general, described herein are apparatuses and methods of using them to collect blood by first ensuring that the patient's skin is properly cleaned, to prevent contamination of the collected blood. Any of the devices described herein may include an integrated controller with a timer having multiple modes to guide a user (e.g., a phlebotomist) in prepping a subject's skin for a blood draw. The system may include a display (visual) and/or audible output to guide the user, such as a pre-configured countdown for a timer that establishes a predetermined cleaning and drying time (and also potentially additional cleaning/drying cycles). The timer may be hands-free, so that the user only has to trigger the first activation, additional time cycles may be triggered automatically. The system may include a controller that also interfaces with the timer and may record compliance. The system may include a restart function, allowing the user to restart the pre-configured countdown if the cleaning and drying time is missed for any reason. Additionally, the system may include an automated restart function, wherein the pre-configured countdown is restarted if a user reaches the end of the cleaning and drying time without proceeding to the blood collection process for longer than a configured time period.


For example, a blood collection apparatus may include a countdown beep during a preparing to clean (prepare to scrub) period and/or a prepare to dry time period, and/or during a drying period and/or during a cleaning period. In some variations the apparatus or method of operating the apparatus includes a countdown beep only during the preparing time periods (e.g., preparing to clean and preparing to dry time periods). During any of these time periods (first preparing to clean time period, first cleaning time period, second preparing to clean time period, second cleaning time period, preparing to dry time period, drying time periods) a visual countdown may be shown on the display, with or without an audible count down. For example, in some variations a visual countdown may be shown on the display only during the scrub and dry time periods (including displaying without an audible countdown). At the beginning and end of any of these time periods (e.g., the scrub and dry periods), a distinctive audible tone may be made to signal the start or end of that period so the phlebotomist need not be watching the display.


For example, described herein are methods of collecting blood from a patient, the method comprising: initiating, in a blood collection device, a scrub timer having a scrub time period; during the scrub time period, disinfecting tissue of the patient at a needle entry site; and after the scrub time period has elapsed, beginning a blood draw process. The method may include emitting one or more audible beeps from the collection device at the start of the scrub period. The method may include emitting one or more audible beeps from the collection device during the scrub period. The tones emitted may be different. For example, the tones emitted at the start of a preparing to dry period, dry period, preparing to clean period, cleaning period, etc. may be different from each other and from the tones emitted to count down these periods. For example, the tones may be different in frequency, pitch, volume, scale, intensity, etc. Thus, for example, the method may include audibly counting down the scrub time period. For example, the method may include emitting a series of audible beeps counting down the scrub period. In some variations, the method may include: initiating, in the blood collection device immediately after the scrub time period has elapsed, a prepare to dry timer having a prepare to dry time period; and audibly counting down the prepare to dry period. The method may also include initiating, in the blood collection device immediately after the scrub time period has elapsed, a prepare to dry timer having a prepare to dry time period; during the prepare to dry period, performing a secondary wash of the patient at the needle entry site; and audibly counting down the prepare to dry period during the prepare to dry time period. After the disinfecting tissue step, the method (system) may automatically initiate in the blood collection device a dry timer having a dry time period; and drying tissue of the patient at the needle entry site during the dry time period.


For example, described herein are methods of collecting blood from a patient, the method comprising: initiating, in a blood collection device, a scrub timer having a scrub time period; audibly counting down the scrub timer during the scrub time period; automatically initiating, in the blood collection device after the scrub time period has elapsed, a dry timer having a dry time period; audibly counting down the dry timer during the dry time period; and beginning a blood draw process after the dry time period has elapsed. The method may also include initiating, in the blood collection device immediately after the scrub time period has elapsed, a prepare to dry timer having a prepare to dry time period; and audibly counting down the prepare to dry period.


Devices and systems configured to implement these methods are also included. For example, a blood collection device may include: a support configured to hold a blood collection bag; a pinch valve configured to engage a tube leading from the blood collection bag to a patient; a controller configured to control the blood collection device including the pinch valve; and a scrub timer coupled to the controller and configured to indicate to a user a scrub time period prior to beginning a blood draw process.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is an illustration of a blood collection device and a control system.



FIG. 2 is a flowchart describing an integrated scrub timer in a blood collection device.





DETAILED DESCRIPTION OF THE DISCLOSURE


FIG. 1 is a diagram showing a blood collection device 106 and optional control system 108. In some embodiments, the blood collection device 106 is a standalone device and does not use or interact with a control system 108. In other embodiments, more than one blood collection device 106 can be networked with and bi-directionally communicate with the control system 108. Blood collection device 106 can provide blood banks and other blood collection centers with an inexpensive yet accurate device for managing and monitoring the collection of blood donations from blood donors. The device is configured to accurately weigh blood donations during the collection process, and to provide blood bag mixing to insure correct disbursement of anticoagulant and alleviate the need for manual mixing by a phlebotomist. Referring to FIG. 1, blood collection device 106 can include a graphical user interface (GUI) 110, a scale or bag tray 112, a pinch valve 114, and a barcode scanner 116. The device can be configured to receive a blood donation bag 118 on the scale and in the pinch valve, as shown. In some embodiments, the blood donation bag comprises a barcode 120 readable via the barcode scanner of the blood collection device.


The GUI 110 allows a user (e.g., a phlebotomist) to configure, calibrate, and setup the blood collection device for use. GUI 110 may display information to the user such as calibration status of the blood collection device 106. In some embodiments, the GUI 110 displays information to the user such as calibration status of the device bag tray 112, weight of the blood donation bag 118, and operation status of the device (e.g., calibration, blood collection underway, blood collection complete, errors during collection, etc.). During initial setup of the device, a user may be asked to zero or calibrate the device, with no weight on the bag tray 112 to ensure accurate measurement of collected blood.


In some embodiments, the device comprises an agitation system suspended on the internal load cell. The agitation system can comprise a motor-driven crank configured to agitate/shake the bag tray 112 and the blood donation bag 118 during blood collection. The agitation system can be designed for minimal weight and optimized for the power required to agitate/shake the bag tray 112 and thus, the blood bag.


When a blood collection bag is placed on the bag tray 112, vertical oscillations of the agitation system can cause blood collected from a donor to flow from one end of the bag to the other, resulting in gentle mixing of the blood and the contained anticoagulant and/or additives. Since the agitation system is mounted on the internal load cell, the load cell can then sense the weight of the bag tray 112, the agitation system, the blood bag, and the accumulated blood.


The blood collection device can further include a pinch valve 114 configured to open and close the blood bag line leading from the patient to the blood donation bag 118. Thus, the blood collection device can be configured to open the pinch valve 114 when the blood collection process begins and close the pinch valve when the blood collection is complete, e.g., when the load cell indicates that the blood donation bag is full.


The blood collection device is configured to automatically measure the weight of accumulated blood during the blood collection process. In some embodiments, the weight of the accumulated blood is measured every time the blood bag and bag tray 112 are in a relatively stable position. In other embodiments, the accumulated blood is measured continuously. By regularly monitoring the weight of collected blood, the blood collection device can calculate blood flow rates from the patient to the blood collection bag. The weight measurements and or flow rates can be used to determine when the blood collection process is complete.


When a blood collection is started, the blood collection device can first implement a series of weight readings of the empty blood bag, the agitation system, and the bag tray assembly. This can be recorded in the device's memory as the tare weight. The desired collection volume can be converted mathematically from weight to volume by using the specific gravity of blood, e.g., of 1.058. (1.00 ml of blood weighs 1.058 grams); this may be configurable on the device between 1.050 to 1.060. This converted weight value plus the tare weight results in the target weight and is compared against on-going weight readings as the collection proceeds. The blood collection device can then open the pinch valve to begin the blood collection process.


The agitation system can be left off until a small increase in weight is seen over the tare weight. As soon as the weight increase is seen by the blood collection device, the agitation system can initiate the shacking/rocking, and various other timing and flow functions can be activated. The blood collection device can continue to read the weight of the blood collection bag. Although these readings are relatively accurate, in some embodiments for greater accuracy, the blood collection system can stop the agitation process when the total weight is slightly less than the target weight. The final readings of collected blood can then be taken with the bag and bag tray in a horizontal position. At this point, it is unnecessary to continue agitating the bag since the anticoagulant is already fully mixed with the blood in the bag. Alternatively, the shaking/rocking could continue throughout the collection provided that accuracy of the weight readings could be assured.


Typically blood bank standards require that blood collections must be completed in a set period of time (20 minutes maximum for current US regulations), smaller volumes of collection can tolerate a slower flow rate. In some embodiments, the blood collection device measures the flow rate and compares it against a computed constant, equal to a minimum flow value for the set period of time described above. As a result, if the required volume is greater, the flow rate must be greater to accomplish the fill in the set period of time (e.g., 20 minutes). If the required volume is less, the flow rate can be slower.


The blood collection device 106 can also include a barcode scanner 116 configured to read a barcode as an input to the device. For example, donation ID's unique to individual donors can be scanned during the blood collection process to keep track of all collection events related to that unique donation ID. In one embodiment, the donation ID can be represented as a barcode 120 located on blood donation bag 118.


The blood collection device 106 can be in communication with control system 108 during all steps of the blood collection process described above (e.g., calibration, blood collection, scrub and dry timing, and completion of the blood draw). The blood collection device and control system can communicate via any technology known in the art, such as wirelessly through a WiFi or Bluetooth connection, or through a wired Ethernet connection. The control system can comprise a computer having all the necessary hardware (e.g., CPU, memory, data storage, etc.) required to execute a data collection and management software.


Scrub Timer


In some embodiments, the blood collection device 106 can include a scrub timer 122. The scrub timer can be configured to aid a phlebotomist in cleaning and preparing a needle entry site prior to blood collection. Some blood collection requirements or guidelines require that a needle entry site of the patient be scrubbed or cleaned for a certain period of time. For example, prepping for a blood collection typically involves disinfecting the tissue around the needle entry site for at least 30 seconds with a 70% or higher alcohol swab, or alternatively, with an iodine solution. The tissue can then be dried before the blood collection process begins. If this disinfecting step is skipped, or if the phlebotomist does not scrub the tissue entry site for the proper amount of time, the blood collected from that patient can be compromised.


Referring still to FIG. 1, a scrub timer 122 can be implemented in the blood collection device 106. The scrub timer 122 can be a visual timer displayed on the GUI 110 (e.g., in the form of a countdown or other visual indicator), or alternatively can be an audible timer that is conveyed to the user or phlebotomist with spoken words, beeping, or other sounds. In some embodiments, the duration of the scrub timer can be pre-set by a user or the phlebotomist, depending on the desired scrub time. In other embodiments, the scrub timer can include both a first timer that tracks the scrubbing or disinfecting process, and second timer that tracks drying of the tissue around the needle entry site after the scrub, or a second scrub. The scrub timer 122 can optionally include a countdown timer before or after each of the first and second timers, to give a user or phlebotomist time to prepare for impending action. The scrub timer 122 can optionally include a manual and/or automated restart function, in which the scrub and/or dry timer is restarted in the blood collection device due to non-compliance. For example, a phlebotomist can manually restart the scrub and/or dry timer if the needle entry site was not prepared properly during the scrub time period, or alternatively, the blood collection device can automatically restart the scrub and/or dry timer if the blood collection process isn't started within a pre-determined period following completion of the scrub and/or dry timer.



FIG. 2 is a flowchart 200 describing the use of the scrub timer described above. All references to a blood collection device or scrub timer in this section can refer to blood collection device 106 and scrub timer 122 of FIG. 1. At step 202 of flowchart 200, a user of a blood collection device, such as phlebotomist, can initiate a blood collection process on the blood collection device. The user can, for example, turn on the blood collection device and push a button on the device to start the process.


Next, at step 204 of flowchart 200, the blood collection device can optionally start a “prepare to scrub” timer. This “prepare to scrub” timer can be displayed or audibly presented to the user to prepare them for the next step. For example, the “prepare to scrub” timer can be a short countdown, e.g., 5 seconds, to indicate to the user of the blood collection device that the scrub step is about to begin. In some embodiments, there is no “prepare to scrub” timer and the blood collection device goes directly from step 202 to step 206, below.


At step 206 of flowchart 200, the blood collection device can start the scrub timer. As described above, the duration of the scrub timer can be pre-set by the user, and can be a visual countdown or timer, or optionally can be audible words, beeps, or sounds. If the scrub timer is a visual countdown or running timer displayed on a GUI of the blood collection device, the user can look at the device to see how much time remains or has passed in the scrub. When the scrub timer begins in step 206, the user or phlebotomist can begin scrubbing the patient's skin surrounding the needle entry site, and can stop the scrubbing process when the scrub timer expires (or reaches the pre-configured scrub time). Scrubbing during the entire duration of the scrub timer ensures that proper scrub protocol has been followed by the phlebotomist.


In some scenarios, a phlebotomist may be required to perform a secondary scrub, or alternatively, may be required to dry the tissue around the needle entry site after the initial scrub. For example, some alcohol based scrubs require that the skin be dried before a needle is inserted into the patient. Alternatively, if an iodine solution is used for the initial scrub, some blood centers require a secondary scrub to further disinfect the patient. In either of these instances, steps 208 and 210 can be optionally implemented with a scrub timer feature of a blood collection device during a blood collection process.


At step 208 of flowchart 200, the blood collection device can optionally start a “prepare to dry” timer. This “prepare to dry” timer can be displayed or audibly presented to the user to prepare them for the next step. For example, the “prepare to dry” timer can be a short countdown, e.g., 5 seconds, to indicate to the user of the blood collection device that the drying step is about to begin. In some embodiments, the “prepare to dry” timer can be replaced with a second “prepare to scrub” timer if a second scrub is required.


At step 210 of flowchart 200, the blood collection device can start the dry timer. As described above, the duration of the dry timer can be pre-set by the user, and can be a visual countdown or timer, or optionally can be audible words, beeps, or sounds. If the dry timer is a visual countdown or running timer displayed on a GUI of the blood collection device, the user can look at the device to see how much time remains or has passed in the drying process. When the dry timer starts in step 210, the user can begin the drying process, and can stop the drying process when the dry timer expires (or reaches the pre-configured dry time). As with step 208, the dry timer can be replaced with an optional second scrub timer if a second scrub is required.


At step 212 of flowchart 200, the scrub and/or dry timer can manually or automatically be restarted. For example, if the phlebotomist fails to comply with the scrub and/or dry timer and realizes the non-compliance, the phlebotomist can interface with the blood collection device to restart the scrub and/or dry timer (e.g., by pushing a button on the device). Alternatively, the blood collection device can automatically restart the scrub and/or dry timer if for example, the phlebotomy process does not begin within a predetermined time period following the completion of the scrub and/or dry time period.


Finally, at step 214 of flowchart 200, the phlebotomy process can begin, and blood can be drawn from the patient. Steps 202-212 above can be implemented in a scrub timer of the blood collection device to ensure that proper scrub protocol is followed, thereby decreasing the chances that the blood collected from the patient is rejected for failing to follow scrub protocol.


When a feature or element is herein referred to as being “on” another feature or element, it can be directly on the other feature or element or intervening features and/or elements may also be present. In contrast, when a feature or element is referred to as being “directly on” another feature or element, there are no intervening features or elements present. It will also be understood that, when a feature or element is referred to as being “connected”, “attached” or “coupled” to another feature or element, it can be directly connected, attached or coupled to the other feature or element or intervening features or elements may be present. In contrast, when a feature or element is referred to as being “directly connected”, “directly attached” or “directly coupled” to another feature or element, there are no intervening features or elements present. Although described or shown with respect to one embodiment, the features and elements so described or shown can apply to other embodiments. It will also be appreciated by those of skill in the art that references to a structure or feature that is disposed “adjacent” another feature may have portions that overlap or underlie the adjacent feature.


Terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the invention. For example, as used herein, the singular forms “a”, “an” and “the” are intended to include the plural forms as well, unless the context clearly indicates otherwise. It will be further understood that the terms “comprises” and/or “comprising,” when used in this specification, specify the presence of stated features, steps, operations, elements, and/or components, but do not preclude the presence or addition of one or more other features, steps, operations, elements, components, and/or groups thereof. As used herein, the term “and/or” includes any and all combinations of one or more of the associated listed items and may be abbreviated as “/”.


Spatially relative terms, such as “under”, “below”, “lower”, “over”, “upper” and the like, may be used herein for ease of description to describe one element or feature's relationship to another element(s) or feature(s) as illustrated in the figures. It will be understood that the spatially relative terms are intended to encompass different orientations of the device in use or operation in addition to the orientation depicted in the figures. For example, if a device in the figures is inverted, elements described as “under” or “beneath” other elements or features would then be oriented “over” the other elements or features. Thus, the exemplary term “under” can encompass both an orientation of over and under. The device may be otherwise oriented (rotated 90 degrees or at other orientations) and the spatially relative descriptors used herein interpreted accordingly. Similarly, the terms “upwardly”, “downwardly”, “vertical”, “horizontal” and the like are used herein for the purpose of explanation only unless specifically indicated otherwise.


Although the terms “first” and “second” may be used herein to describe various features/elements, these features/elements should not be limited by these terms, unless the context indicates otherwise. These terms may be used to distinguish one feature/element from another feature/element. Thus, a first feature/element discussed below could be termed a second feature/element, and similarly, a second feature/element discussed below could be termed a first feature/element without departing from the teachings of the present invention.


As used herein in the specification and claims, including as used in the examples and unless otherwise expressly specified, all numbers may be read as if prefaced by the word “about” or “approximately,” even if the term does not expressly appear. The phrase “about” or “approximately” may be used when describing magnitude and/or position to indicate that the value and/or position described is within a reasonable expected range of values and/or positions. For example, a numeric value may have a value that is +/−0.1% of the stated value (or range of values), +/−1% of the stated value (or range of values), +/−2% of the stated value (or range of values), +/−5% of the stated value (or range of values), +/−10% of the stated value (or range of values), etc. Any numerical range recited herein is intended to include all sub-ranges subsumed therein.


Although various illustrative embodiments are described above, any of a number of changes may be made to various embodiments without departing from the scope of the invention as described by the claims. For example, the order in which various described method steps are performed may often be changed in alternative embodiments, and in other alternative embodiments one or more method steps may be skipped altogether. Optional features of various device and system embodiments may be included in some embodiments and not in others. Therefore, the foregoing description is provided primarily for exemplary purposes and should not be interpreted to limit the scope of the invention as it is set forth in the claims.


The examples and illustrations included herein show, by way of illustration and not of limitation, specific embodiments in which the subject matter may be practiced. As mentioned, other embodiments may be utilized and derived there from, such that structural and logical substitutions and changes may be made without departing from the scope of this disclosure. Such embodiments of the inventive subject matter may be referred to herein individually or collectively by the term “invention” merely for convenience and without intending to voluntarily limit the scope of this application to any single invention or inventive concept, if more than one is, in fact, disclosed. Thus, although specific embodiments have been illustrated and described herein, any arrangement calculated to achieve the same purpose may be substituted for the specific embodiments shown. This disclosure is intended to cover any and all adaptations or variations of various embodiments. Combinations of the above embodiments, and other embodiments not specifically described herein, will be apparent to those of skill in the art upon reviewing the above description.

Claims
  • 1. A method of collecting blood from a patient, the method comprising: initiating, in a blood collection device, a scrub timer having a scrub time period;during the scrub time period, disinfecting skin tissue of the patient at a needle entry site with a disinfectant; andafter the scrub time period has elapsed, beginning a blood draw process with the blood collection device.
  • 2. The method of claim 1, further comprising emitting one or more audible beeps from an audible output of the collection device during the scrub period.
  • 3. The method of claim 1, further comprising emitting one or more audible beeps from an audible output of the collection device to indicate the start of the scrub period.
  • 4. The method of claim 1, further comprising audibly counting down the scrub time period with an audible output of the collection device.
  • 5. The method of claim 1, further comprising visibly counting down the scrub time period with a graphical user interface of the collection device.
  • 6. The method of claim 1, further comprising emitting a series of audible beeps counting down the scrub period with an audible output of the collection device.
  • 7. The method of claim 1, further comprising: initiating, in the blood collection device immediately after the scrub time period has elapsed, a prepare to dry timer having a prepare to dry time period; and counting down the prepare to dry period.
  • 8. The method of claim 7, further comprising emitting one or more audible beeps from an audible output of the collection device to indicate a start of the prepare to dry time period.
  • 9. The method of claim 7, further comprising audibly counting down the prepare to dry time period with an audible output of the collection device.
  • 10. The method of claim 7, further comprising emitting one or more audible beeps counting down the prepare to dry time period with an audible output of the collection device.
  • 11. The method of claim 7, further comprising visibly counting down the prepare to dry time period with a graphical user interface of the collection device.
  • 12. The method of claim 1, further comprising: initiating, in the blood collection device immediately after the scrub time period has elapsed, a prepare to dry timer having a prepare to dry time period; during the prepare to dry period, performing a secondary wash of the skin tissue of the patient at the needle entry site; and counting down the prepare to dry period.
  • 13. The method of claim 1, further comprising: after the disinfecting tissue step, automatically initiating in the blood collection device a dry timer having a dry time period; and drying skin tissue of the patient at the needle entry site during the dry time period.
  • 14. The method of claim 1, further comprising emitting one or more audible beeps from an audible output of the collection device during the scrub period.
  • 15. The method of claim 1, further comprising emitting one or more audible beeps from an audible output of the collection device to indicate a start of the scrub period.
  • 16. The method of claim 1, further comprising audibly counting down the scrub time period with an audible output of the collection device.
  • 17. The method of claim 1, further comprising visibly counting down the scrub time period with a graphical user interface of the collection device.
  • 18. The method of claim 1, further comprising emitting a series of audible beeps counting down the scrub period with an audible output of the collection device.
  • 19. The method of claim 1, further comprising; before the scrub time period, initiating, in a blood collection device, a prepare to scrub timer having a prepare to scrub time period; and counting down the prepare to scrub time.
  • 20. The method of claim 1, further comprising automatically restarting the scrub timer if the blood draw process does not begin within a pre-determined time period following the scrub time period.
  • 21. A method of collecting blood from a patient, the method comprising: initiating, in a blood collection device, a scrub timer having a scrub time period;visibly and/or audibly counting down the scrub timer during the scrub time period with a graphical user interface and/or an audible output of the blood collection device;automatically initiating, in the blood collection device after the scrub time period has elapsed, a dry timer having a dry time period;visibly and/or audibly counting down the dry timer during the dry time period with the graphical user interface and/or the audible output of the blood collection device; andbeginning a blood draw process with the blood collection device after the dry time period has elapsed.
  • 22. The method of claim 21, further comprising initiating, in the blood collection device immediately before the scrub time period, a prepare to scrub period; and visibly or audibly counting down the prepare to scrub period with the graphical user interface or the audible output of the blood collection device.
  • 23. The method of claim 21, further comprising emitting one or more audible beeps from an audible output of the blood collection device before initiating the dry time period.
  • 24. The method of claim 21, further comprising emitting one or more audible beeps from an audible output of the blood collection device before initiating the scrub time period.
  • 25. The method of claim 21, further comprising initiating, in the blood collection device immediately after the scrub time period has elapsed, a prepare to dry timer having a prepare to dry time period; and visibly or audibly counting down the prepare to dry period with the graphical user interface or the audible output of the blood collection device.
  • 26. The method of claim 1 wherein the disinfectant comprises an alcohol solution.
  • 27. The method of claim 1 wherein the disinfectant comprises an iodine solution.
CROSS REFERENCE TO RELATED APPLICATIONS

This application claims the benefit under 35 U.S.C. 119 of U.S. Provisional Patent Application No. 62/005,673, filed May 30, 2014, titled “SYSTEMS AND METHODS FOR MANAGING BLOOD DONATIONS”. This application is herein incorporated by reference in its entirety.

US Referenced Citations (342)
Number Name Date Kind
4083363 Philpot, Jr. Apr 1978 A
4377852 Thompson Mar 1983 A
4451158 Selwyn May 1984 A
RE33924 Valeri May 1992 E
5403279 Inaba et al. Apr 1995 A
5403304 Ishida Apr 1995 A
5611048 Jacobs et al. Mar 1997 A
5658240 Urdahl et al. Aug 1997 A
5666500 Roberson Sep 1997 A
5845289 Baumeister et al. Dec 1998 A
5857194 Kelliher et al. Jan 1999 A
5912669 Hsia Jun 1999 A
5973665 Davie et al. Oct 1999 A
6008811 McMillan Dec 1999 A
6014702 King et al. Jan 2000 A
6026684 Calder Feb 2000 A
6049832 Brim et al. Apr 2000 A
6113554 Gilcher et al. Sep 2000 A
6131510 Gasquez Oct 2000 A
6216164 Zaremba Apr 2001 B1
6233525 Langley et al. May 2001 B1
6252591 Dockweiler et al. Jun 2001 B1
6256643 Cork et al. Jul 2001 B1
6259447 Kanetake et al. Jul 2001 B1
6289382 Bowman Amuah Sep 2001 B1
6327624 Mathewson et al. Dec 2001 B1
6332163 Bowman Amuah Dec 2001 B1
6334144 Horwitz Dec 2001 B1
6339832 Bowman Amuah Jan 2002 B1
6342905 Diedrich et al. Jan 2002 B1
6366658 Bjornberg et al. Apr 2002 B1
6381654 Brawn et al. Apr 2002 B1
6402702 Gilcher et al. Jun 2002 B1
6405924 Shah Jun 2002 B1
6406919 Tyrrell Jun 2002 B1
6434568 Bowman Amuah Aug 2002 B1
6434628 Bowman Amuah Aug 2002 B1
6438594 Bowman Amuah Aug 2002 B1
6442748 Bowman Amuah Aug 2002 B1
6446110 Lection et al. Sep 2002 B1
6453356 Sheard et al. Sep 2002 B1
6477580 Bowman Amuah Nov 2002 B1
6477665 Bowman Amuah Nov 2002 B1
6480895 Gray et al. Nov 2002 B1
6496850 Bowman Amuah Dec 2002 B1
6502213 Bowman Amuah Dec 2002 B1
6508778 Verkaart et al. Jan 2003 B1
6511439 Tabata et al. Jan 2003 B1
6519605 Gilgen et al. Feb 2003 B1
6529909 Bowman Amuah Mar 2003 B1
6529948 Bowman Amuah Mar 2003 B1
6539396 Bowman Amuah Mar 2003 B1
6549949 Bowman Amuah Apr 2003 B1
6550057 Bowman Amuah Apr 2003 B1
6571282 Bowman Amuah May 2003 B1
6578068 Bowman Amuah Jun 2003 B1
6582386 Min et al. Jun 2003 B2
6601192 Bowman Amuah Jul 2003 B1
6601234 Bowman Amuah Jul 2003 B1
6606660 Bowman Amuah Aug 2003 B1
6611806 Harvey Aug 2003 B1
6615199 Bowman Amuah Sep 2003 B1
6615253 Bowman Amuah Sep 2003 B1
6622176 Jones et al. Sep 2003 B2
6636242 Bowman Amuah Oct 2003 B2
6640238 Bowman Amuah Oct 2003 B1
6640244 Bowman Amuah Oct 2003 B1
6640249 Bowman Amuah Oct 2003 B1
6641552 Kingsley et al. Nov 2003 B1
6665868 Knowles et al. Dec 2003 B1
6673314 Burbank et al. Jan 2004 B1
6714945 Foote et al. Mar 2004 B1
6715145 Bowman Amuah Mar 2004 B1
6718334 Han Apr 2004 B1
6730054 Pierce et al. May 2004 B2
6742015 Bowman Amuah May 2004 B1
6773413 Keller et al. Aug 2004 B2
6808503 Farrell et al. Oct 2004 B2
6816880 Strandberg et al. Nov 2004 B1
6842906 Bowman Amuah Jan 2005 B1
6862573 Kendall et al. Mar 2005 B2
6884228 Brown et al. Apr 2005 B2
6934848 King et al. Aug 2005 B1
6944596 Gray et al. Sep 2005 B1
6949079 Westberg et al. Sep 2005 B1
6976164 King et al. Dec 2005 B1
6980989 Silverman et al. Dec 2005 B2
6994790 Corbin et al. Feb 2006 B2
6996542 Landry Feb 2006 B1
7072769 Fletcher Haynes et al. Jul 2006 B2
7076032 Pirasteh et al. Jul 2006 B1
7087047 Kraus et al. Aug 2006 B2
7169352 Felt et al. Jan 2007 B1
7219094 Schiel et al. May 2007 B2
7269844 Elteto et al. Sep 2007 B2
7289964 Bowman Amuah Oct 2007 B1
7334015 Phillips Feb 2008 B1
7354415 Bainbridge et al. Apr 2008 B2
7373373 McElhannon May 2008 B2
7380024 Peterson et al. May 2008 B2
7415438 Berman et al. Aug 2008 B1
7421427 DeForeest et al. Sep 2008 B2
7430478 Fletcher-Haynes et al. Sep 2008 B2
7434166 Acharya et al. Oct 2008 B2
7454399 Matichuk Nov 2008 B2
7475143 Hartmann et al. Jan 2009 B2
7479123 Briggs Jan 2009 B2
7540021 Page May 2009 B2
7558777 Santos Jul 2009 B1
7566315 Hirabuki Jul 2009 B2
7574376 Berman et al. Aug 2009 B1
7597250 Finn Oct 2009 B2
7704454 Langley et al. Apr 2010 B1
7708710 Min et al. May 2010 B2
7739227 Jordan et al. Jun 2010 B2
7752178 Anderson Jul 2010 B2
7754149 Sugiyama Jul 2010 B2
7844472 Akin et al. Nov 2010 B1
7844521 Hoag et al. Nov 2010 B1
7850634 Briggs Dec 2010 B2
7860726 Connely et al. Dec 2010 B2
7877402 Weiss et al. Jan 2011 B1
7900298 Char et al. Mar 2011 B1
7937583 Thornton et al. May 2011 B2
7949546 Klieman et al. May 2011 B1
7962899 McCullough et al. Jun 2011 B2
7992203 Relyea Aug 2011 B2
8036987 Grbac et al. Oct 2011 B1
8060382 Lee et al. Nov 2011 B1
8060423 Rukonic et al. Nov 2011 B1
8060500 Fitch et al. Nov 2011 B1
8086730 Ribak et al. Dec 2011 B2
8108227 Rogers et al. Jan 2012 B1
8108271 Duncan et al. Jan 2012 B1
8146000 Boliek et al. Mar 2012 B1
8155950 Bickerstaff Apr 2012 B1
8166473 Kinsey et al. Apr 2012 B2
8170958 Gremett et al. May 2012 B1
8185426 Khoubyari May 2012 B1
8196061 Bhojan Jun 2012 B1
8204805 Eftekhari et al. Jun 2012 B2
8209229 Weiss et al. Jun 2012 B1
8214276 Preece et al. Jul 2012 B1
8219504 Weiss et al. Jul 2012 B1
8280787 Gandhi Oct 2012 B1
8285622 Rao et al. Oct 2012 B1
8286199 Pulaski et al. Oct 2012 B1
8291047 Liu et al. Oct 2012 B2
8296206 Del Favero et al. Oct 2012 B1
8306255 Degnan Nov 2012 B1
8321309 Jain et al. Nov 2012 B1
8326725 Elwell et al. Dec 2012 B2
8335728 Dahodwala et al. Dec 2012 B1
8346753 Hayes Jan 2013 B2
8346929 Lai Jan 2013 B1
8352350 Del Favero et al. Jan 2013 B1
8364522 Gevelber Jan 2013 B1
8375324 Zubizarreta et al. Feb 2013 B1
8380590 Rukonic et al. Feb 2013 B1
8407113 Eftekhari et al. Mar 2013 B1
8452748 Pugh May 2013 B1
8463622 Garms et al. Jun 2013 B2
8468130 Bhandari et al. Jun 2013 B2
8473263 Tolone et al. Jun 2013 B2
8473858 Buchanan et al. Jun 2013 B2
8484626 Nagulu et al. Jul 2013 B2
8495596 Safavi-Naini Jul 2013 B1
8521628 Gowen et al. Aug 2013 B1
8527291 Kochendorfer Sep 2013 B1
8543932 Fields et al. Sep 2013 B2
8566313 Zubizarreta et al. Oct 2013 B1
8568356 Lebel et al. Oct 2013 B2
8571885 Andros et al. Oct 2013 B2
8600835 Lueck Dec 2013 B1
8640105 Yaffe Jan 2014 B2
8649770 Cope et al. Feb 2014 B1
8655726 Favero et al. Feb 2014 B1
8660945 Pariante et al. Feb 2014 B1
8668138 Schwarz et al. Mar 2014 B1
8688504 Reisman Apr 2014 B2
8689016 Morten et al. Apr 2014 B2
8707409 Shah et al. Apr 2014 B2
8713005 Benson Apr 2014 B2
8744197 Fertik et al. Jun 2014 B2
8744923 McKay et al. Jun 2014 B1
8751292 Del Favero et al. Jun 2014 B2
8752170 Newstadt et al. Jun 2014 B1
8768833 Freishtat et al. Jul 2014 B2
8775070 Bhatia Jul 2014 B1
8793777 Colson Jul 2014 B2
8798596 Shuster et al. Aug 2014 B2
8826145 Kirkpatrick et al. Sep 2014 B1
20020013523 Csore et al. Jan 2002 A1
20020087356 Andros et al. Jul 2002 A1
20020116219 Ibok et al. Aug 2002 A1
20030004751 Ng et al. Jan 2003 A1
20030032868 Graskov et al. Feb 2003 A1
20030037023 Lyakovetsky et al. Feb 2003 A1
20030040835 Ng et al. Feb 2003 A1
20030069480 Ng et al. Apr 2003 A1
20030120593 Bansal et al. Jun 2003 A1
20030154108 Fletcher Haynes et al. Aug 2003 A1
20030002002 Wells et al. Oct 2003 A1
20030229846 Sethi et al. Dec 2003 A1
20040046787 Henry et al. Mar 2004 A1
20040103040 Ronaghi et al. May 2004 A1
20040117376 Lavin et al. Jun 2004 A1
20040153432 O'Halloran et al. Aug 2004 A1
20040171983 Sparks et al. Sep 2004 A1
20040193613 Armand Sep 2004 A1
20040214148 Salvino et al. Oct 2004 A1
20040230216 LeVaughn et al. Nov 2004 A1
20040267562 Fuhrer et al. Dec 2004 A1
20050038675 Siekman et al. Feb 2005 A1
20050071193 Kalies Mar 2005 A1
20050096973 Heyse et al. May 2005 A1
20050137908 Fusari et al. Jun 2005 A1
20050182726 Honeycutt et al. Aug 2005 A1
20050204900 Burton Sep 2005 A1
20050234964 Batra et al. Oct 2005 A1
20050240437 Cunningham Oct 2005 A1
20050243655 McCutcheon et al. Nov 2005 A1
20050278261 Omanson et al. Dec 2005 A1
20060026067 Nicholas et al. Feb 2006 A1
20060026519 Vaindiner et al. Feb 2006 A1
20060075224 Tao Apr 2006 A1
20060085478 Landau et al. Apr 2006 A1
20060111943 Wu May 2006 A1
20060190566 Roach Aug 2006 A1
20060247971 Dresden et al. Nov 2006 A1
20070055483 Lee et al. Mar 2007 A1
20070106647 Schwalb May 2007 A1
20070112574 Greene May 2007 A1
20070130111 Stoudt et al. Jun 2007 A1
20070143660 Huey et al. Jun 2007 A1
20070198744 Wensley et al. Aug 2007 A1
20070219826 Brodsky et al. Sep 2007 A1
20070220494 Spooner Sep 2007 A1
20070250390 Lee et al. Oct 2007 A1
20070276678 Nichols Nov 2007 A1
20070282280 Tennican Dec 2007 A1
20080064986 Kraemer et al. Mar 2008 A1
20080097952 Eswaran Apr 2008 A1
20080132311 Walker Jun 2008 A1
20080133551 Wensley et al. Jun 2008 A1
20080133736 Wensley et al. Jun 2008 A1
20080148160 Holmes et al. Jun 2008 A1
20080208750 Chen Aug 2008 A1
20090037264 Del Favero et al. Feb 2009 A1
20090037266 Weiss et al. Feb 2009 A1
20090048870 Godshall et al. Feb 2009 A1
20090076885 Fein et al. Mar 2009 A1
20090187462 Gevelber et al. Jul 2009 A1
20090191174 Boudreau et al. Jul 2009 A1
20090204964 Foley et al. Aug 2009 A1
20090288037 Lawton et al. Nov 2009 A1
20100049542 Benjamin et al. Feb 2010 A1
20100049576 Wilson et al. Feb 2010 A1
20100063838 Schumacher et al. Mar 2010 A1
20100083358 Govindarajan et al. Apr 2010 A1
20100100424 Buchanan et al. Apr 2010 A1
20100138241 Ruark et al. Jun 2010 A1
20100142447 Schlicht et al. Jun 2010 A1
20100168615 Amano et al. Jul 2010 A1
20100205112 Reynolds et al. Aug 2010 A1
20100215280 Abdo et al. Aug 2010 A1
20100256974 Xu et al. Oct 2010 A1
20100269049 Fearon Oct 2010 A1
20100306080 Trandal et al. Dec 2010 A1
20110010214 Carruth Jan 2011 A1
20110022425 Block et al. Jan 2011 A1
20110041153 Simon et al. Feb 2011 A1
20110047230 McGee Feb 2011 A1
20110106759 Brown May 2011 A1
20110130114 Boudville Jun 2011 A1
20110191254 Womack Aug 2011 A1
20120010553 Alqvist et al. Jan 2012 A1
20120016721 Weinman Jan 2012 A1
20120022892 Feldman et al. Jan 2012 A1
20120036565 Gamez et al. Feb 2012 A1
20120054625 Pugh et al. Mar 2012 A1
20120072232 Frankham et al. Mar 2012 A1
20120096021 Wiser et al. Apr 2012 A1
20120130962 Wiser et al. May 2012 A1
20120136678 Steinberg May 2012 A1
20120173397 Elwell et al. Jul 2012 A1
20120191703 Huff Jul 2012 A1
20120191716 Omoigui Jul 2012 A1
20120215560 Wartenfeld et al. Aug 2012 A1
20120218127 Kroen Aug 2012 A1
20120253801 Santos-Lang et al. Oct 2012 A1
20120265099 Goodnow et al. Oct 2012 A1
20120329529 van der Raadt Dec 2012 A1
20130030889 Davich et al. Jan 2013 A1
20130061323 Liske Mar 2013 A1
20130096501 Arene et al. Apr 2013 A1
20130138501 Litzow et al. May 2013 A1
20130202482 Froimson Aug 2013 A1
20130204778 Connors et al. Aug 2013 A1
20130290408 Stephure et al. Oct 2013 A1
20130291024 Lefevre et al. Oct 2013 A1
20130297349 Epstein et al. Nov 2013 A1
20130304496 Rangadass Nov 2013 A1
20130339858 Corfield Dec 2013 A1
20130346144 Ferren et al. Dec 2013 A1
20130346527 Shah et al. Dec 2013 A1
20140004949 Miura et al. Jan 2014 A1
20140004956 Miura et al. Jan 2014 A1
20140033230 Hanna et al. Jan 2014 A1
20140046678 Lacy et al. Feb 2014 A1
20140052469 Andros et al. Feb 2014 A1
20140052680 Nitz et al. Feb 2014 A1
20140052681 Nitz et al. Feb 2014 A1
20140077932 Rooyakkers Mar 2014 A1
20140088998 Boyer et al. Mar 2014 A1
20140095363 Caldwell Apr 2014 A1
20140096226 Barkan Apr 2014 A1
20140108397 Zubizarreta et al. Apr 2014 A1
20140115679 Barton et al. Apr 2014 A1
20140122135 Bain May 2014 A1
20140136280 Farahat et al. May 2014 A1
20140136541 Farahat et al. May 2014 A1
20140143270 Amulu et al. May 2014 A1
20140149842 Murthy et al. May 2014 A1
20140156345 Eskey et al. Jun 2014 A1
20140164484 Vonog et al. Jun 2014 A1
20140172625 Reisman Jun 2014 A1
20140172751 Greenwood Jun 2014 A1
20140180802 Boal Jun 2014 A1
20140188649 Messinger et al. Jul 2014 A1
20140189048 Messinger et al. Jul 2014 A1
20140189851 Domke et al. Jul 2014 A1
20140189876 Messinger et al. Jul 2014 A1
20140207521 Onder et al. Jul 2014 A1
20140207601 Soorianarayanan et al. Jul 2014 A1
20140207862 Domke et al. Jul 2014 A1
20140207874 Soorianarayanan et al. Jul 2014 A1
20140207875 Messinger et al. Jul 2014 A1
20140208159 Soorianarayanan et al. Jul 2014 A1
20140208163 Domke et al. Jul 2014 A1
20140244453 Rephlo Aug 2014 A1
20150073832 Goodnow et al. Mar 2015 A1
Foreign Referenced Citations (14)
Number Date Country
1348740 May 2002 CN
1503954 Jun 2004 CN
1674030 Sep 2005 CN
101982006 Feb 2011 CN
1470781 Oct 2004 EP
2465421 Jun 2012 EP
2435113 Aug 2007 GB
08-240589 Sep 1996 JP
2003-0063426 Jul 2003 KR
2005-0072937 Jul 2005 KR
2005-0075502 Jul 2005 KR
2008-0017470 Feb 2008 KR
WO2002069793 Sep 2002 WO
WO2015184462 Dec 2015 WO
Non-Patent Literature Citations (7)
Entry
WHO Guidelines for drawing blood, May 19, 2010. http://www.who.int/injection_safety/phleb_final_screen_ready.pdf.
World Health Organization; WHO guidelines on drawing blood; © 2010; 5 pages; retrieved from the internet (http://www.ncbi.nim.nih.gov/books/NBK138671) on Aug. 14, 2015.
Armstrong; Blood Collection; ISBT Science Series; 3(2); pp. 123-136; Jun. 2008.
McDonald et al.; A novel rapid and effective donor arm disinfection method; Transfusion; 50(1); pp. 53-58; Jan. 2010.
Patel et al.; Impact of donor arm cleaning with different aseptic solutions for prevention of contamination in blood bags; Indian Journal of Hematol Blood Transfus; 29(1); pp. 17-20; Mar. 2013.
Kappestin; Nasokomiale Infektionen Pravention; Labordiagnostik; Antimkrobielle Therapie Thieme; 4th Edition; Jul. 15, 2009 (English Abstract).
Trautmann et al.; Anforderungen an die Hygiene bei Punktionen und Injektionen. Bundesgesundheitsblatt; Gesundheitsforschung; Gesundheitsschutz; vol. 54; pp. 1135-1144; Sep. 2011 (English Abstract).
Related Publications (1)
Number Date Country
20150343123 A1 Dec 2015 US
Provisional Applications (1)
Number Date Country
62005673 May 2014 US